TrialArchives of osteoporosis2017

Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.

A Fahrleitner-Pammer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.